Tevogen Bio, a clinical stage biotechnology company, has expanded its leadership team with two new executives to support the biotech’s rapid operational growth, manufacturing readiness, and the continued development and utilization of its next generation precision T cell platform technology.   New hires include: Stephen Chen, Chief Technical Officer Stephen Chen, MBA, has more than 18 years of biotech industry experience. He was most recently chief operating officer and chief technical of...